<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kandala PK</submitter><funding>NCI NIH HHS</funding><pagination>297-309</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2917853</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>78(2)</volume><pubmed_abstract>We evaluated the effect of 3,3'-diindolylmethane (DIM) in ovarian cancer cells. DIM treatment inhibited the growth of SKOV-3, TOV-21G, and OVCAR-3 ovarian cancer cells in both a dose- and time-dependent manner with effective concentrations ranging from 40 to 100 muM. Growth-inhibitory effects of DIM were mediated by cell cycle arrest in G(2)/M phase in all the three cell lines. G(2)/M arrest was associated with DNA damage as indicated by phosphorylation of H(2)A.X at Ser139 and activation of checkpoint kinase 2 (Chk2) in all the three cell lines. Other G(2)/M regulatory molecules such as Cdc25C, Cdk1, cyclin B1 were down-regulated by DIM. Cycloheximide or Chk2 inhibitor pretreatment abrogated not only activation of Chk2 but also G(2)/M arrest and apoptosis mediated by DIM. To further estab</pubmed_abstract><journal>Molecular pharmacology</journal><pubmed_title>Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.</pubmed_title><pmcid>PMC2917853</pmcid><funding_grant_id>R01-CA106953</funding_grant_id><funding_grant_id>R01 CA129038</funding_grant_id><funding_grant_id>R01-CA129038</funding_grant_id><funding_grant_id>R01 CA106953</funding_grant_id><pubmed_authors>Srivastava SK</pubmed_authors><pubmed_authors>Kandala PK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.</name><description>We evaluated the effect of 3,3'-diindolylmethane (DIM) in ovarian cancer cells. DIM treatment inhibited the growth of SKOV-3, TOV-21G, and OVCAR-3 ovarian cancer cells in both a dose- and time-dependent manner with effective concentrations ranging from 40 to 100 muM. Growth-inhibitory effects of DIM were mediated by cell cycle arrest in G(2)/M phase in all the three cell lines. G(2)/M arrest was associated with DNA damage as indicated by phosphorylation of H(2)A.X at Ser139 and activation of checkpoint kinase 2 (Chk2) in all the three cell lines. Other G(2)/M regulatory molecules such as Cdc25C, Cdk1, cyclin B1 were down-regulated by DIM. Cycloheximide or Chk2 inhibitor pretreatment abrogated not only activation of Chk2 but also G(2)/M arrest and apoptosis mediated by DIM. To further estab</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Aug</publication><modification>2025-04-18T15:50:26.221Z</modification><creation>2019-03-27T00:33:05Z</creation></dates><accession>S-EPMC2917853</accession><cross_references><pubmed>20444961</pubmed><doi>10.1124/mol.110.063750</doi></cross_references></HashMap>